Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA, NCI Collaboration Deepens To Include Clinical Trial Innovation ‘Think Tank’

Executive Summary

Former NCI Director Monica Bertagnolli, who now is head of the NIH, said FDA, NCI and National Clinical Trials Network officials are working on potential clinical trial system innovations.

You may also be interested in...



US FDA’s Pazdur Wants Clinicians To Help Set Oncology Research Agenda

Oncology Center of Excellence director said clinical trial participation may increase if the research questions are ‘significant to answer.’

Could NIH Help US FDA Answer More Postmarketing Questions?

FDA Commissioner Robert Califf said pharma should not be the sole entity handling postmarket research.

Lingering Leqembi Question: When Should Treatment Stop?

Several questions about the anti-amyloid product used to treat Alzheimer’s remain, which could affirm calls for more US FDA, CMS and NIH collaboration on research.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS149367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel